23.01.2015 Views

Hope Not Hype - Third World Network

Hope Not Hype - Third World Network

Hope Not Hype - Third World Network

SHOW MORE
SHOW LESS
  • No tags were found...

Create successful ePaper yourself

Turn your PDF publications into a flip-book with our unique Google optimized e-Paper software.

Appendix One: What is a GMO<br />

129<br />

Appendix One<br />

What is a GMO<br />

JUST saying what a genetically modified organism (GMO) is, is complicated. Text<br />

approved in the Biotechnology theme of the Synthesis Report drew attention to this issue<br />

in connection with the definition of modern biotechnology and its products, particularly<br />

transgenic organisms:<br />

Currently the most contentious issue is the use of recombinant DNA [rDNA] techniques to<br />

produce transgenes that are inserted into genomes. Even newer techniques of modern<br />

biotechnology manipulate heritable material without changing DNA.<br />

To illustrate the importance of this issue, I will use the case of double-stranded RNA<br />

(dsRNA, Box A1.1) and how it is viewed under New Zealand’s regulations. As this case<br />

involves concepts that are highly technical, the following is an overview of the generic<br />

issue at stake.<br />

Box A1.1: Double-stranded RNA is genetic material<br />

Double-stranded RNA is an alternate means of creating genetic modifications that can<br />

affect the properties of organisms without necessarily changing their DNA.<br />

RNA is genetic material for two reasons. First, it is unambiguously the nucleic acid<br />

genome of some viruses. Second, RNA molecules that are reproduced using ubiquitous<br />

enzymatic activities can in some organisms or circumstances demonstrate the ability to<br />

transfer traits or characteristics infectiously or across generations. These are the same<br />

criteria used to originally identify DNA as genetic material (Heinemann and Roughan,<br />

2000).<br />

The use of dsRNA in genetic modification is growing and it is currently the basis for<br />

pre-commercial research to develop products such as caffeine-free coffee and insecticide<br />

plants (Gordon and Waterhouse, 2007; Ogita et al., 2003). Yet because its heritability<br />

has not been understood until relatively recently, it will not always be covered by<br />

appropriate legal and regulatory standards set for risk assessment even though it is a<br />

nucleic acid and therefore covered by the Cartagena Protocol on Biosafety. Definitions<br />

will often determine whether a new understanding in science is covered or not, and it is<br />

in such instances that these definitions carry considerable importance.

Hooray! Your file is uploaded and ready to be published.

Saved successfully!

Ooh no, something went wrong!